Twenty years after SDM’s introduction, health plans are seizing on it to help patients choose their treatments. The lower costs for these patients are a welcome extra.
The Catalyst for Payment Reform finds that only 10 percent of care is paid through new methods, but its executive director says shared goals and incremental change will make a difference
That is just one of the considerations that a biotech developer must consider when creating a new product
There’s still a way to go in reducing elective deliveries, and different insurance systems feel far different effects
As different sectors of the drug industry battle, pharmacists may follow the easier — and more expensive — path
Insurers and employers apply a three-prong approach to what some experts are describing as hyperinflation
A summary of ECRI Institute’s Health Technology Forecast Report
BlueCross BlueShield of South Carolina anticipated the problem years ago and invites you to join in what could be a solution